Zobrazeno 1 - 10
of 203
pro vyhledávání: '"Chronic systolic heart failure"'
Autor:
Sunit‐Preet Chaudhry, Adam D. DeVore, Himabindu Vidula, Michael Nassif, Karol Mudy, Edo Y. Birati, Timothy Gong, Pavan Atluri, Duc Pham, Benjamin Sun, Aditya Bansal, Samer S. Najjar
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 24 (2022)
Durable implantable left ventricular assist devices (LVADs) have been shown to improve survival and quality of life for patients with stage D heart failure. Even though LVADs remain underused overall, the number of patients with heart failure support
Externí odkaz:
https://doaj.org/article/b815e522031c4f2084d9e3afecbe4ac6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Львівський клінічний вісник, Vol 2-3, Iss 14-15, Pp 63-70 (2016)
Introduction. Quality of life (QoL) of patients with chronic heart failure (CHF) is an integral part of a comprehensive analysis of their condition and helps to evaluate the effectiveness of various methods of treatment and rehabilitation. Using dif
Externí odkaz:
https://doaj.org/article/f03e628032854ef18c4b1b96efb97029
Autor:
Agnieszka Surowiec, Daniel Rogowicz, Łukasz Wołowiec, Bartosz Kochański, Małgorzata Wołowiec, Anna Plaskiewicz, Alicja Krakowska, Walery Zukow
Publikováno v:
Journal of Education, Health and Sport, Vol 5, Iss 8, Pp 11-22 (2015)
Surowiec Agnieszka, Rogowicz Daniel, Wołowiec Łukasz, Kochański Bartosz, Wołowiec Małgorzata, Plaskiewicz Anna, Krakowska Alicja, Zukow Walery. Przydatność rokownicza nowych markerów w przewlekłej skurczowej niewydolności serca = The progno
Externí odkaz:
https://doaj.org/article/18e4794b36224c7caf2305caedf5c6d2
Publikováno v:
EP Europace. 23:496-510
In chronic systolic heart failure and conduction system disease, cardiac resynchronization therapy (CRT) is the only known non-pharmacologic heart failure therapy that improves cardiac function, functional capacity, and survival while decreasing card
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e888774dbd744f1cd8cd3c0bbf726a61
https://doi.org/10.1093/europace/euaa264
https://doi.org/10.1093/europace/euaa264
Autor:
Guido Strunk, Joachim Struck, Martin Hülsmann, Philipp E. Bartko, Helmuth Haslacher, Henrike Arfsten, Georg Goliasch, Noemi Pavo, Georg Spinka, Johannes Novak, Suriya Prausmüller, Anna Cho
Publikováno v:
British Journal of Clinical Pharmacology. 87:916-924
The clinically investigated rationale for neprilysin (NEP)-inhibition by angiotensinreceptor-NEPinhibitor (ARNi) therapy is to induce elevations in endogenous natriuretic peptides. NEP, however, cleaves a broad spectrum of substrates, which partially
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5813d14f0cff894778892690e7b4c24e
https://doi.org/10.1111/bcp.14442
https://doi.org/10.1111/bcp.14442
Autor:
Tor Biering-Sørensen, John R. Teerlink, Fady I. Malik, Brian Claggett, Jason C. Legg, Christopher E. Kurtz, Narimon Honarpour, Scott D. Solomon, John J.V. McMurray, Masatoshi Minamisawa, Jiankang Liu, G. Michael Felker, Alexander Papolos
Publikováno v:
European journal of heart failureReferences. 23(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc333463b67d831267b58dffff5dd8d6
https://pubmed.ncbi.nlm.nih.gov/33826209
https://pubmed.ncbi.nlm.nih.gov/33826209
Autor:
Peter Göttel, Tong Li, L. Christian Napp, Kersten Brandes, Johannes Müller, Guenes Dogan, Jan D. Schmitto, Johann Bauersachs, Axel Haverich, Jasmin S. Hanke, Jens Vogel-Claussen, Silvia Mariani
Publikováno v:
ASAIO journal (American Society for Artificial Internal Organs : 1992). 68(7)
Current therapies significantly improve survival and clinical endpoints in patients suffering from chronic heart failure with reduced ejection fraction (HFrEF), but most are not sufficient to reverse adverse remodeling and improve myocardial contract
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b7c418653ce7ee2f9d48f3a3acb3dc8
https://pubmed.ncbi.nlm.nih.gov/34324448
https://pubmed.ncbi.nlm.nih.gov/34324448
Publikováno v:
European Heart Journal. 41:1764-1774
Despite improvements in outcomes in the last few decades for heart failure (HF) with reduced ejection fraction (HFrEF), there still remains a need for novel therapies as many patients incompletely recover with existing therapies and progress to advan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90b37c8e27a3ccf957c3733b5b794e34
https://doi.org/10.1093/eurheartj/ehz364
https://doi.org/10.1093/eurheartj/ehz364
Publikováno v:
Research Results in Biomedicine. 7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eee8792feacd39ee436c3c3562059130
https://doi.org/10.18413/2658-6533-2021-7-2-0-10
https://doi.org/10.18413/2658-6533-2021-7-2-0-10